ASTRAZENECA PHARMA INDIA
Quarterly Results Analysis [Dec2023]
ASTRAZENECA PHARMA INDIA Quarterly Results
Standalone | Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 UnAudited |
Dec2022 UnAudited |
Sep2022 UnAudited |
Jun2022 UnAudited |
Mar2022 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹306 Cr | ₹311 Cr | ₹295 Cr | ₹285 Cr | ₹250 Cr | ₹236 Cr | ₹232 Cr | ₹232 Cr |
Expenses | ₹291 Cr | ₹258 Cr | ₹228 Cr | ₹225 Cr | ₹213 Cr | ₹195 Cr | ₹204 Cr | ₹194 Cr |
Operating Income | ₹15 Cr | ₹53 Cr | ₹67 Cr | ₹60 Cr | ₹37 Cr | ₹41 Cr | ₹28 Cr | ₹38 Cr |
Other Income | ₹10 Cr | ₹8 Cr | ₹8 Cr | ₹8 Cr | ₹7 Cr | ₹7 Cr | ₹4 Cr | ₹4 Cr |
Interest | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Depreciation | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹3 Cr | ₹5 Cr | ₹4 Cr |
Profit Before Tax | ₹20 Cr | ₹73 Cr | ₹71 Cr | ₹23 Cr | ₹39 Cr | ₹44 Cr | ₹27 Cr | ₹37 Cr |
Profit After Tax | ₹16 Cr | ₹52 Cr | ₹54 Cr | ₹17 Cr | ₹29 Cr | ₹33 Cr | ₹20 Cr | ₹28 Cr |
EPS | ₹6.32 | ₹20.95 | ₹21.54 | ₹6.91 | ₹11.72 | ₹13.03 | ₹8.06 | ₹11.19 |
Industry Peers & Returns | 1W | 1M | 1Y |
ASTRAZENECA PHARMA INDIA | -0.3% | -8% | 53% |
SUN PHARMACEUTICAL INDUSTRIES | 3% | 2.3% | 68.2% |
CIPLA | 2.5% | 0.4% | 71.7% |
DR REDDYS LABORATORIES | -0.2% | -4.9% | 40.3% |
ZYDUS LIFESCIENCES | 5% | 10.4% | 109.1% |
DIVIS LABORATORIES | -1.6% | -7% | 23.8% |
MANKIND PHARMA | NA | NA | NA |
TORRENT PHARMACEUTICALS | 2.9% | -2.2% | 69% |
LUPIN | 2.8% | 0% | 147.8% |
ASTRAZENECA PHARMA INDIA Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -1.70 % |
Y-o-Y | 22.41 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2023 | ₹306 Cr | -1.70 | |
Sep2023 | ₹311 Cr | 5.28 | |
Jun2023 | ₹295 Cr | 3.78 | |
Mar2023 | ₹285 Cr | 13.97 | |
Dec2022 | ₹250 Cr | 5.79 | |
Sep2022 | ₹236 Cr | 1.63 | |
Jun2022 | ₹232 Cr | 0.16 | |
Mar2022 | ₹232 Cr | - |
ASTRAZENECA PHARMA INDIA Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -71.46 % |
Y-o-Y | -58.85 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2023 | ₹15 Cr | -71.46 | |
Sep2023 | ₹53 Cr | -21.54 | |
Jun2023 | ₹67 Cr | 12.36 | |
Mar2023 | ₹60 Cr | 63.57 | |
Dec2022 | ₹37 Cr | -10.16 | |
Sep2022 | ₹41 Cr | 45.63 | |
Jun2022 | ₹28 Cr | -26.33 | |
Mar2022 | ₹38 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -70.99 % |
Y-o-Y | -66.42 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2023 | 4.92% | -70.99 | |
Sep2023 | 16.96% | -25.48 | |
Jun2023 | 22.76% | 8.28 | |
Mar2023 | 21.02% | 43.48 | |
Dec2022 | 14.65% | -15.07 | |
Sep2022 | 17.25% | 43.27 | |
Jun2022 | 12.04% | -26.45 | |
Mar2022 | 16.37% | - |
ASTRAZENECA PHARMA INDIA Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -69.83 % |
Y-o-Y | -46.09 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2023 | ₹16 Cr | -69.83 | |
Sep2023 | ₹52 Cr | -2.77 | |
Jun2023 | ₹54 Cr | 211.85 | |
Mar2023 | ₹17 Cr | -41.07 | |
Dec2022 | ₹29 Cr | -10.01 | |
Sep2022 | ₹33 Cr | 61.57 | |
Jun2022 | ₹20 Cr | -27.98 | |
Mar2022 | ₹28 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -69.30 % |
Y-o-Y | -55.92 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2023 | 5.17 % | -69.30 | |
Sep2023 | 16.84 % | -7.62 | |
Jun2023 | 18.23 % | 200.33 | |
Mar2023 | 6.07 % | -48.25 | |
Dec2022 | 11.73 % | -14.94 | |
Sep2022 | 13.79 % | 58.87 | |
Jun2022 | 8.68 % | -28.03 | |
Mar2022 | 12.06 % | - |
ASTRAZENECA PHARMA INDIA Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -69.83 % |
Y-o-Y | -46.08 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2023 | ₹6.32 | -69.83 | |
Sep2023 | ₹20.95 | -2.74 | |
Jun2023 | ₹21.54 | 211.72 | |
Mar2023 | ₹6.91 | -41.04 | |
Dec2022 | ₹11.72 | -10.05 | |
Sep2022 | ₹13.03 | 61.66 | |
Jun2022 | ₹8.06 | -27.97 | |
Mar2022 | ₹11.19 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD